Corpus ID: 209336887

Myocardial fi brosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from Cardiovascular Magnetic Resonance imaging

@inproceedings{Rijsingen2019MyocardialFB,
  title={Myocardial fi brosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from Cardiovascular Magnetic Resonance imaging},
  author={I. Rijsingen and J. P. Tintelen and P. L. V. Haelst and R. N. Planken and R. A. Boer and A. Suurmeijer and D. J. Veldhuisen},
  year={2019}
}
1 Citations

Figures and Tables from this paper

Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
  • 7
  • PDF

References

SHOWING 1-10 OF 37 REFERENCES
Association for European Paediatric and Congenital Cardiology (AEPC)
  • 35
  • PDF
Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation
  • 2015
Accuracy and reproducibility of semi - automated late gadolinium enhancement quantifi cation techniques in patients with hypertrophic cardiomyopathy
  • J Cardiovasc Magn Reson
  • 2014
Myocardial T1 mapping: modalities and clinical applications.
  • 68
Outcome in phospholamban R 14 del carriers : results of a large multicentre cohort study
  • Circ Cardiovasc Genet
  • 2014
cation techniques in patients with hypertrophic cardiomyopathy
  • J Cardiovasc Magn Reson
  • 2014
...
1
2
3
4
...